MTOR and hepatocellular carcinoma: 5′AMP-activated protein kinase (AMPK) and the mammalian target of rapamycin (mTOR) are two serine/threonine protein kinases and potential targets for cancer chemotherapy against hepatocellular carcinoma cells.